Cargando…
The JAK2 pathway is activated in idiopathic pulmonary fibrosis
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is the most rapidly progressive and fatal fibrotic disorder, with no curative therapies. The signal transducer and activator of transcription 3 (STAT3) protein is activated in lung fibroblasts and alveolar type II cells (ATII), thereby contributing to...
Autores principales: | Milara, Javier, Hernandez, Gracia, Ballester, Beatriz, Morell, Anselm, Roger, Inés, Montero, P., Escrivá, Juan, Lloris, José M., Molina-Molina, Maria, Morcillo, Esteban, Cortijo, Julio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801676/ https://www.ncbi.nlm.nih.gov/pubmed/29409529 http://dx.doi.org/10.1186/s12931-018-0728-9 |
Ejemplares similares
-
Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets
por: Ballester, Beatriz, et al.
Publicado: (2019) -
MUC16 Is Overexpressed in Idiopathic Pulmonary Fibrosis and Induces Fibrotic Responses Mediated by Transforming Growth Factor-β1 Canonical Pathway
por: Ballester, Beatriz, et al.
Publicado: (2021) -
IL-11 system participates in pulmonary artery remodeling and hypertension in pulmonary fibrosis
por: Milara, Javier, et al.
Publicado: (2022) -
The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension
por: Roger, Inés, et al.
Publicado: (2021) -
Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
por: Montero, Paula, et al.
Publicado: (2021)